INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,236 Cr | ₹2,475 Cr | ₹2,137 Cr | ₹1,284 Cr | ₹559 Cr |
What is the latest Total Liabilities ratio of INDEGENE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,236 Cr |
| Mar2024 | ₹2,475 Cr |
| Mar2023 | ₹2,137 Cr |
| Mar2022 | ₹1,284 Cr |
| Mar2021 | ₹559 Cr |
How is Total Liabilities of INDEGENE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,236 Cr | 30.76 | |
| Mar2024 | ₹2,475 Cr | 15.82 | |
| Mar2023 | ₹2,137 Cr | 66.38 | |
| Mar2022 | ₹1,284 Cr | 129.63 | |
| Mar2021 | ₹559 Cr | - | |
Compare Total Liabilities of peers of INDEGENE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDEGENE | ₹11,193.6 Cr | 4.8% | -7% | -22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
INDEGENE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDEGENE | 4.8% |
-7% |
-22.5% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses